Search

As expected, 2023 has proven to be a tough year for dealmakers. We'll discuss how this has impacted M&A insurance and due diligence and go over our predictions for 2024.

Learn about what a purpose trust is and how you can protect it.

In part one of our Risk Management for Your Life Sciences Company series, we break down the unique exposures companies face during the Research & Development: Pre-Human Clinical Trials stage.

The IRS has released their PCORI fees for plan years ending before October 2024.

Get caught up on cyber trends, common cyber exposure misconceptions, how to respond to a breach, and what's covered and not covered by cyber insurance.

Learn about some common reasons US-based companies place a local D&O policy in foreign jurisdictions as well as approaches you can take to provide local admitted coverage.

The DOL, IRS, and HHS released FAQs About Affordable Care Act Implementation Part 61 (“FAQ Part 61”) which addresses lingering questions about enforcement of the Transparency in Coverage Final Rules (TiC Final Rules).